Mark J. Foley
2019
In 2019, Mark J. Foley earned a total compensation of $17.2M as President and Chief Executive Officer at Revance Therapeutics.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Option Awards | $5,112,573 |
| Salary | $189,764 |
| Stock Awards | $11,728,370 |
| Other | $9,723 |
| Total | $17,190,430 |
Foley received $11.7M in stock awards, accounting for 68% of the total pay in 2019.
Foley also received $150K in bonus, $5.1M in option awards, $189.8K in salary and $9.7K in other compensation.
Rankings
In 2019, Mark J. Foley's compensation ranked 244th out of 13,971 executives tracked by ExecPay. In other words, Foley earned more than 98.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 244 out of 13,971 | 98th |
Division Manufacturing | 88 out of 5,701 | 99th |
Major group Chemicals And Allied Products | 23 out of 2,200 | 99th |
Industry group Drugs | 19 out of 1,886 | 99th |
Industry Pharmaceutical Preparations | 16 out of 1,398 | 99th |
Source: SEC filing on March 26, 2020.
Foley's colleagues
We found five more compensation records of executives who worked with Mark J. Foley at Revance Therapeutics in 2019.
2019
L Browne
Revance Therapeutics
Chief Executive Officer
2019
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
2019
Caryn McDowell
Revance Therapeutics
General Counsel
2019
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
2019
Dustin Sjuts
Revance Therapeutics